Getinge AB (publ) (GNGBY)
OTCMKTS · Delayed Price · Currency is USD
20.87
+0.35 (1.69%)
Aug 12, 2025, 2:31 PM EDT
Getinge AB Market Cap
Getinge AB has a market cap or net worth of $5.61 billion as of August 12, 2025. Its market cap has increased by 7.79% in one year.
Market Cap
5.61B
Enterprise Value
6.59B
Revenue
3.73B
Ranking
n/a
PE Ratio
35.80
Stock Price
$20.87
Market Cap Chart
Since March 15, 1996, Getinge AB's market cap has increased from 2.25B to 5.61B, an increase of 149.81%. That is a compound annual growth rate of 3.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 5.61B | 25.28% |
| Dec 30, 2024 | 4.48B | -26.09% |
| Dec 29, 2023 | 6.06B | 7.18% |
| Dec 30, 2022 | 5.65B | -52.49% |
| Dec 30, 2021 | 11.90B | 86.32% |
| Dec 30, 2020 | 6.39B | 25.58% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.23M |
| Glass House Brands | 561.16M |
| American Oncology Network | 385.65M |
| Northwest Biotherapeutics | 360.45M |
| CytoDyn | 300.75M |